Immuron (Warrant)

YTD

ALL

Why Robinhood?

You can watch IMRNW and buy or sell other stocks, ETFs, and their options commission-free!

About IMRNW

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments.

CEO

Steven Lydeamore, MBA

CEOSteven Lydeamore, MBA

Employees

—

Employees—

Headquarters

Blackburn, Victoria (VIC)

HeadquartersBlackburn, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRNW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

Immuron (Warrant)(IMRNW) trades at $0.07.

On 2025-12-11, Immuron (Warrant)(IMRNW) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Immuron (Warrant)(IMRNW) stock has reached 0.

IMRNW News

TipRanks 20h

Immuron Limited Issues New Shares to Bolster Financial Position

TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...

TipRanks 2d

Why Is Immuron Stock Down Today?

Immuron (IMRN) stock fell hard on Wednesday after the biopharmaceutical company announced results from the Uniformed Services University’s P2TD study of enterot...